In a post hoc analysis of a cohort of 995 patients with severe sepsis or septic shock participating in the ALBIOS trial, Masson S. et al.14 showed high levels of hs-cTnT in up to 84.5% of septic shock patients. The gene discussed is TNNT2; the disease is Sepsis.